Red Light Holland Successfully Imports Psilocybin iMicrodose Packs into St. Vincent and the Grenadines Under a First-Ever Authorized Import Approval Process by the Country’s Bureau of Standards and the Ministry of Health

3 years ago

Red Light Holland's licensed subsidiary Scarlette Lillie Sciences and Innovation granted authorization for first ever psilocybin import into St. Vincent…

CENTR’s Explosive Retail Growth Continues in 2022

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 21, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),…

Canadian Psychedelic Research Company Lophos Pharmaceuticals Inc. Engages KGK Science for Novel Peyote Study

3 years ago

Toronto, Ontario--(Newsfile Corp. - March 21, 2022) - Lophos Pharmaceuticals Inc., a Canadian psychedelic research company focused on cultivation and…

AI voice-driven speech recognition suite, Augnito, enhances radiology and clinical reporting for Wellbeing Software

3 years ago

Bespoke speech recognition technology, Augnito, aids Wellbeing Software with highly accurate Radiology Information System workflows. Scribetech has announced the integration…

AlzeCure Presents New Preclinical Alzstatin Data at Alzheimer Conference

3 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 21, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical…

15 Dosell are Implemented in a New Municipality

3 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 21, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Zafe…

IRLAB Nominates New Candidate Drug, IRL757, to Treat Apathy in Neurological Disorders

3 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / March 21, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) takes important steps…

Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme

3 years ago

FIRST DOSING OF A STUDY PARTICIPANT TRIGGERS MILESTONE PAYMENT OF € 3 M TO EVOTECPHASE II CLINICAL TRIAL INITIATED BY…

Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales

3 years ago

Proven Pharmaceutical Sales Professional Brings Big Pharma Experience to Relief's U.S. Expansion ActivitiesGENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022…

Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

3 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), announced today that it has…